Pre-order Enquiry
Request Free Sample
Healthcare
Aerospace & Defence
Agriculture
Automations
Chemicals & Advanced Materials
Food & Beverages
Information & Communication Technology
Oil & Gas
Power & Energy
The global Early Phase Clinical Trial Outsourcings market size was valued at USD 8587.35 Million in 2022 and will reach USD 11560.59 Million in 2028, with a CAGR of 5.08% during 2022-2028.
There are 3 main phases of clinical trials – phases 1 to 3. But trials have an earlier stage called phase 1,Phase 1 trials are usually the earliest trials of drugs in people. But your doctor might ask if you would like to join a phase 1 study. Phase 1 studies usually only involve a small number of people and they only have a very small dose of a drug. The dose of the drug is too small to treat your cancer,
Region Overview:
North America had the highest growth rate of all regions.
Company Overview:
IQVIA is one of the major players operating in the Early Phase Clinical Trial Outsourcings market, holding a share of 15.48% in 2018.
IQVIA Holdings Inc. provides integrated information and technology-enabled healthcare services in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Commercial Solutions, Research & Development Solutions, and Integrated Engagement Services. The Commercial Solutions segment offers a range of cloud-based applications and related implementation, real-world insights, and reference information services; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services. This segment also provides country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical.
Syneos Health, Inc. operates as an integrated biopharmaceutical solutions company in North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates through two segments, Clinical Solutions and Commercial Solutions. The Clinical Solutions segment offers various clinical development services spanning Phase I to Phase IV, including full-service global studies, as well as unbundled service offerings, such as clinical monitoring, investigator recruitment, patient recruitment, data management, and study startup to assist customers with drug development process. The Commercial Solutions segment provides commercialization services.
Segmentation Overview:
By type, Clinical Data Management (CDM) segment accounted for the largest share of market in 2021.
Application Overview:
By application, the Pharmaceutical Companies segment occupied the biggest share from 2017 to 2022.
The Early Phase Clinical Trial Outsourcings market report covers sufficient and comprehensive data on market introduction, segmentations, status and trends, opportunities and challenges, industry chain, competitive analysis, company profiles, and trade statistics, etc. It provides in-depth and all-scale analysis of each segment of types, applications, players, 5 major regions and sub-division of major countries, and sometimes end user, channel, technology, as well as other information individually tailored before order confirmation.
Meticulous research and analysis were conducted during the preparation process of the report. The qualitative and quantitative data were gained and verified through primary and secondary sources, which include but not limited to Magazines, Press Releases, Paid Databases, Maia Data Center, National Customs, Annual Reports, Public Databases, Expert interviews, etc. Besides, primary sources include extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs, and marketing executives, downstream distributors, as well as end-clients.
In this report, the historical period starts from 2018 to 2022, and the forecast period ranges from 2023 to 2028. The facts and data are demonstrated by tables, graphs, pie charts, and other pictorial representations, which enhances the effective visual representation and decision-making capabilities for business strategy.
Key Companies in the global Early Phase Clinical Trial Outsourcings market covered in Chapter 4:
Sofpromed
PPD
SGS life Science
Syneos Health
PRA Health Sciences
Charles River Laboratories
PAREXEL International Corporation
Quanticate
Covance
Chiltern International Ltd
ICON Plc
IQVIA
In Chapter 12 and Chapter 14.1, on the basis of types, the Early Phase Clinical Trial Outsourcings market from 2018 to 2028 is primarily split into:
Regulatory Services
Clinical Data Management (CDM)
Medical Writing
Site Management
Pharmacovigilance (PV)
Risk-Based Monitoring
Bio Statistical Services
Protocol Development
Others
In Chapter 13 and Chapter 14.2, on the basis of the Downstream Industry, the Early Phase Clinical Trial Outsourcings market from 2018 to 2028 covers:
Pharmaceutical Companies
Biopharmaceutical Companies
Drug Discovery Companies
Medical Devices Companies
Other
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, history and forecast (2018-2028) of the following regions are covered in Chapters 6, 7, 8, 9, 10, 11, 15:
North America (United States, Canada, Mexico)
Europe (Germany, United Kingdom, France, Italy, Spain)
Asia Pacific (China, Japan, South Korea, India, Southeast Asia)
South America (Brazil, Argentina)
Middle East & Africa (Saudi Arabia, UAE, South Africa)
Outline:
Chapter 1 begins with the Early Phase Clinical Trial Outsourcings market scope and definition, product segment introduction, global overall market size, as well as market dynamics scenarios such as opportunities, challenges, and industry development trends under inflation. It offers a high-level view of the current state of the Early Phase Clinical Trial Outsourcings market and its likely evolution in the short to mid-term and long term.
Chapter 2 provides Early Phase Clinical Trial Outsourcings industry chain analysis, covering raw materials analysis, cost structure, price estimate, and forecast, along with price-impacting factors, downstream channels, and major customers. It aims to help readers to grab insights into product upstream, midstream, and downstream fields.
Chapter 3 depicts Early Phase Clinical Trial Outsourcings industry competitive analysis regarding market concentration rate, saturation rate, feasibility analysis from new entrants, as well as substitute's status and trends. It indicates the developing space and prospects of the current industry.
Chapter 4 analyzes extensive company profiles, comprising company basic info, product or service profiles, and sales, price, value, gross, and gross margin 2018-2023. It incorporates the Early Phase Clinical Trial Outsourcings market ranking, benchmarks, and company business portfolio.
Chapter 5 presents trade statistics of import and export volume from 2018-2023, demonstrating domestic and international market comparisons in specific countries.
Chapters 6-10 highlight Early Phase Clinical Trial Outsourcings market status at the regional and country levels, including 5 major regions of North America, Europe, Asia Pacific, the Middle East and Africa, and Latin America. The region and country list in the sample is only for reference, and it can be adjusted as required.
Chapter 11 involves geographical market figures of sales, value, market share, and growth rate. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of each specific region.
Chapters 12-13 evaluate the Early Phase Clinical Trial Outsourcings market based on different types and applications. It focuses on sales and value of 2018-2023 from both vertical and horizontal perspectives.
Chapters 14-15 elaborate on the Early Phase Clinical Trial Outsourcings market forecast data from 2023-2028, segmented by types and applications, regions, and major countries, helping readers to know future aspects and growth trends.
Chapter 16 ends with an elaboration of data sources and research methodology. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
2022
There are 3 main phases of clinical trials – phases 1 to 3. But trials have an earlier stage called phase 1,Phase 1 trials are usually the earliest trials of drugs in people. But your doctor might ask if you would like to join a phase 1 study. Phase 1 studies usually only involve a small number of people and they only have a very small dose of a drug. The dose of the drug is too small to treat your cancer,
Region Overview:
North America had the highest growth rate of all regions.
Company Overview:
IQVIA is one of the major players operating in the Early Phase Clinical Trial Outsourcings market, holding a share of 15.48% in 2018.
IQVIA Holdings Inc. provides integrated information and technology-enabled healthcare services in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Commercial Solutions, Research & Development Solutions, and Integrated Engagement Services. The Commercial Solutions segment offers a range of cloud-based applications and related implementation, real-world insights, and reference information services; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services. This segment also provides country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical.
Syneos Health, Inc. operates as an integrated biopharmaceutical solutions company in North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates through two segments, Clinical Solutions and Commercial Solutions. The Clinical Solutions segment offers various clinical development services spanning Phase I to Phase IV, including full-service global studies, as well as unbundled service offerings, such as clinical monitoring, investigator recruitment, patient recruitment, data management, and study startup to assist customers with drug development process. The Commercial Solutions segment provides commercialization services.
Segmentation Overview:
By type, Clinical Data Management (CDM) segment accounted for the largest share of market in 2021.
Application Overview:
By application, the Pharmaceutical Companies segment occupied the biggest share from 2017 to 2022.
The Early Phase Clinical Trial Outsourcings market report covers sufficient and comprehensive data on market introduction, segmentations, status and trends, opportunities and challenges, industry chain, competitive analysis, company profiles, and trade statistics, etc. It provides in-depth and all-scale analysis of each segment of types, applications, players, 5 major regions and sub-division of major countries, and sometimes end user, channel, technology, as well as other information individually tailored before order confirmation.
Meticulous research and analysis were conducted during the preparation process of the report. The qualitative and quantitative data were gained and verified through primary and secondary sources, which include but not limited to Magazines, Press Releases, Paid Databases, Maia Data Center, National Customs, Annual Reports, Public Databases, Expert interviews, etc. Besides, primary sources include extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs, and marketing executives, downstream distributors, as well as end-clients.
In this report, the historical period starts from 2018 to 2022, and the forecast period ranges from 2023 to 2028. The facts and data are demonstrated by tables, graphs, pie charts, and other pictorial representations, which enhances the effective visual representation and decision-making capabilities for business strategy.
Key Companies in the global Early Phase Clinical Trial Outsourcings market covered in Chapter 4:
Sofpromed
PPD
SGS life Science
Syneos Health
PRA Health Sciences
Charles River Laboratories
PAREXEL International Corporation
Quanticate
Covance
Chiltern International Ltd
ICON Plc
IQVIA
In Chapter 12 and Chapter 14.1, on the basis of types, the Early Phase Clinical Trial Outsourcings market from 2018 to 2028 is primarily split into:
Regulatory Services
Clinical Data Management (CDM)
Medical Writing
Site Management
Pharmacovigilance (PV)
Risk-Based Monitoring
Bio Statistical Services
Protocol Development
Others
In Chapter 13 and Chapter 14.2, on the basis of the Downstream Industry, the Early Phase Clinical Trial Outsourcings market from 2018 to 2028 covers:
Pharmaceutical Companies
Biopharmaceutical Companies
Drug Discovery Companies
Medical Devices Companies
Other
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, history and forecast (2018-2028) of the following regions are covered in Chapters 6, 7, 8, 9, 10, 11, 15:
North America (United States, Canada, Mexico)
Europe (Germany, United Kingdom, France, Italy, Spain)
Asia Pacific (China, Japan, South Korea, India, Southeast Asia)
South America (Brazil, Argentina)
Middle East & Africa (Saudi Arabia, UAE, South Africa)
Outline:
Chapter 1 begins with the Early Phase Clinical Trial Outsourcings market scope and definition, product segment introduction, global overall market size, as well as market dynamics scenarios such as opportunities, challenges, and industry development trends under inflation. It offers a high-level view of the current state of the Early Phase Clinical Trial Outsourcings market and its likely evolution in the short to mid-term and long term.
Chapter 2 provides Early Phase Clinical Trial Outsourcings industry chain analysis, covering raw materials analysis, cost structure, price estimate, and forecast, along with price-impacting factors, downstream channels, and major customers. It aims to help readers to grab insights into product upstream, midstream, and downstream fields.
Chapter 3 depicts Early Phase Clinical Trial Outsourcings industry competitive analysis regarding market concentration rate, saturation rate, feasibility analysis from new entrants, as well as substitute's status and trends. It indicates the developing space and prospects of the current industry.
Chapter 4 analyzes extensive company profiles, comprising company basic info, product or service profiles, and sales, price, value, gross, and gross margin 2018-2023. It incorporates the Early Phase Clinical Trial Outsourcings market ranking, benchmarks, and company business portfolio.
Chapter 5 presents trade statistics of import and export volume from 2018-2023, demonstrating domestic and international market comparisons in specific countries.
Chapters 6-10 highlight Early Phase Clinical Trial Outsourcings market status at the regional and country levels, including 5 major regions of North America, Europe, Asia Pacific, the Middle East and Africa, and Latin America. The region and country list in the sample is only for reference, and it can be adjusted as required.
Chapter 11 involves geographical market figures of sales, value, market share, and growth rate. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of each specific region.
Chapters 12-13 evaluate the Early Phase Clinical Trial Outsourcings market based on different types and applications. It focuses on sales and value of 2018-2023 from both vertical and horizontal perspectives.
Chapters 14-15 elaborate on the Early Phase Clinical Trial Outsourcings market forecast data from 2023-2028, segmented by types and applications, regions, and major countries, helping readers to know future aspects and growth trends.
Chapter 16 ends with an elaboration of data sources and research methodology. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Years considered for this report:
Historical Years:
2018-2022Base Year:
2022Estimated Year:
2023Forecast Period:
2023-2028Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
